🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the Efficacy, Safety and Tolerability profile of CSL...
Status
Completed
Location
The Clinical Trials Unit, Canberra Hospital
Start Date
2008-03
Trial ID
NCT00562484
Treatments Being Tested
The purpose of this study is to see how the body reacts to different streng...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00964951
Treatments Being Tested
The purpose of this study is to assess the humoral immune response and safe...
Status
Completed
Location
Covance Clinical Research Unit AG
Start Date
2010-10
Trial ID
NCT01229371
A Phase IV, Open Label, Multi-Centre Study to Evaluate the Safety and Toler...
Status
Completed
Location
The Canberra Hospital
Start Date
2009-03
Trial ID
NCT00825162
This is a study to assess the immune (antibody) response and safety of the ...
Status
Completed
Location
Study Site
Start Date
2012-05
Trial ID
NCT01591837
Treatments Being Tested
The purpose of this study is to determine the Safety, Tolerability \& Immun...
Status
Completed
Location
Murdoch Childrens Research Institute
Start Date
2005-03
Trial ID
NCT00700193
Treatments Being Tested
This is a study to assess the safety of a bioCSL split virion, inactivated ...
Status
Completed
Location
Site 286
Start Date
2014-09
Trial ID
NCT02212106
The purpose of this study is to determine the immunogenicity and safety pro...
Status
Completed
Location
North Central Arkansas Medical Association
Start Date
2008-10
Trial ID
NCT00735475
Treatments Being Tested
The purpose of this study is to assess the humoral immune response and safe...
Status
Completed
Location
Covance Clinical Research Unit AG
Start Date
2011-10
Trial ID
NCT01412281
The purpose of this study is to investigate the effectiveness, safety, and ...
Status
Completed
Location
Stanford University
Start Date
2006-06
Trial ID
NCT00333398